Maddalena Centanni

410 total citations
13 papers, 311 citations indexed

About

Maddalena Centanni is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Maddalena Centanni has authored 13 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Maddalena Centanni's work include Pharmacogenetics and Drug Metabolism (3 papers), Receptor Mechanisms and Signaling (2 papers) and HER2/EGFR in Cancer Research (2 papers). Maddalena Centanni is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Receptor Mechanisms and Signaling (2 papers) and HER2/EGFR in Cancer Research (2 papers). Maddalena Centanni collaborates with scholars based in Sweden, Netherlands and France. Maddalena Centanni's co-authors include J. G. Coen van Hasselt, Iñaki F. Trocóniz, Dirk Jan A. R. Moes, Joseph Ciccolini, Lena E. Friberg, Yin Cheong Wong, Elizabeth C. M. de Lange, Sreenath M. Krishnan, Mats O. Karlsson and Ingrid M.E. Desar and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Cancer Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Maddalena Centanni

10 papers receiving 305 citations

Peers

Maddalena Centanni
Jan Pander Netherlands
Chaozheng Zhou China
Sara A. Väyrynen Finland
Samira El Bouazzaoui Netherlands
Liviawati Sutjandra United States
Kelsey Klute United States
Arthur Géraud France
Susann Theile Denmark
Rafid Salim Jabir Malaysia
Qingyu Wang China
Jan Pander Netherlands
Maddalena Centanni
Citations per year, relative to Maddalena Centanni Maddalena Centanni (= 1×) peers Jan Pander

Countries citing papers authored by Maddalena Centanni

Since Specialization
Citations

This map shows the geographic impact of Maddalena Centanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maddalena Centanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maddalena Centanni more than expected).

Fields of papers citing papers by Maddalena Centanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maddalena Centanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maddalena Centanni. The network helps show where Maddalena Centanni may publish in the future.

Co-authorship network of co-authors of Maddalena Centanni

This figure shows the co-authorship network connecting the top 25 collaborators of Maddalena Centanni. A scholar is included among the top collaborators of Maddalena Centanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maddalena Centanni. Maddalena Centanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Centanni, Maddalena, Afroditi Nanou, Leon W.M.M. Terstappen, et al.. (2025). Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer. Clinical Pharmacology & Therapeutics. 119(2). 403–413.
2.
3.
Centanni, Maddalena, et al.. (2024). Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children. Cancer Chemotherapy and Pharmacology. 94(2). 297–310. 1 indexed citations
4.
Centanni, Maddalena, et al.. (2024). Pharmacogenetic Testing or Therapeutic Drug Monitoring: A Quantitative Framework. Clinical Pharmacokinetics. 63(6). 871–884. 2 indexed citations
5.
Centanni, Maddalena, et al.. (2024). Integrated modeling of biomarkers, survival and safety in clinical oncology drug development. Advanced Drug Delivery Reviews. 216. 115476–115476. 3 indexed citations
6.
7.
Centanni, Maddalena, Lena E. Friberg, Mats O. Karlsson, et al.. (2024). Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia. Leukemia. 38(4). 712–719. 4 indexed citations
8.
9.
Centanni, Maddalena, Abel Thijs, Ingrid M.E. Desar, Mats O. Karlsson, & Lena E. Friberg. (2022). Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors. Clinical and Translational Science. 16(1). 73–84. 3 indexed citations
10.
Centanni, Maddalena, Sreenath M. Krishnan, & Lena E. Friberg. (2020). Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 26(17). 4590–4598. 10 indexed citations
11.
Centanni, Maddalena & Lena E. Friberg. (2020). Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors. Frontiers in Pharmacology. 11. 316–316. 10 indexed citations
12.
Centanni, Maddalena, Dirk Jan A. R. Moes, Iñaki F. Trocóniz, Joseph Ciccolini, & J. G. Coen van Hasselt. (2019). Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors. Clinical Pharmacokinetics. 58(7). 835–857. 259 indexed citations
13.
Wong, Yin Cheong, Maddalena Centanni, & Elizabeth C. M. de Lange. (2019). Physiologically Based Modeling Approach to Predict Dopamine D2 Receptor Occupancy of Antipsychotics in Brain: Translation From Rat to Human. The Journal of Clinical Pharmacology. 59(5). 731–747. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Pander Breakdown of academic impact, for papers by Chaozheng Zhou Breakdown of academic impact, for papers by Sara A. Väyrynen Breakdown of academic impact, for papers by Samira El Bouazzaoui Breakdown of academic impact, for papers by Liviawati Sutjandra Breakdown of academic impact, for papers by Kelsey Klute Breakdown of academic impact, for papers by Arthur Géraud Breakdown of academic impact, for papers by Susann Theile Breakdown of academic impact, for papers by Rafid Salim Jabir Breakdown of academic impact, for papers by Qingyu Wang
Rankless by CCL
2026